A radiobiological Markov simulation tool for aiding decision making in proton therapy referral

Physica Medica - Tập 44 - Trang 72-82 - 2017
Annabelle M. Austin1, Michael J.J. Douglass1,2, Giang T. Nguyen3, Scott N. Penfold1,2
1Department of Physics, University of Adelaide, Adelaide, SA 5005, Australia
2Department of Medical Physics, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia
3School of Mathematical Sciences, University of Adelaide, Adelaide, SA 5005, Australia

Tài liệu tham khảo

Armoogum, 2015, Dosimetric comparison and potential for improved clinical outcomes of paediatric CNS patients treated with protons or IMRT, Cancers, 7, 706, 10.3390/cancers7020706

Steneker, 2006, Intensity modulated photon and proton therapy for the treatment of head and neck tumors, Radiother Oncol, 80, 263, 10.1016/j.radonc.2006.07.025

Langendijk, 2013, Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach, Radiother Oncol, 107, 267, 10.1016/j.radonc.2013.05.007

Stokkevåg, 2017, Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy, Physica Med, 10.1016/j.ejmp.2017.04.022

Yoshimura, 2016, NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies–A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT), Physica Med, 32, 1095, 10.1016/j.ejmp.2016.08.007

Magni, 2000, Deciding when to intervene: a Markov decision process approach, Int J Med Inf, 60, 237, 10.1016/S1386-5056(00)00099-X

Hauskrecht, 2000, Planning treatment of ischemic heart disease with partially observable Markov decision processes, Artif Intell Med, 18, 221, 10.1016/S0933-3657(99)00042-1

Alagoz, 2010, Markov decision processes: a tool for sequential decision making under uncertainty, Med Decis Making, 30, 474, 10.1177/0272989X09353194

Siebert, 2012, State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3, Value Health, 15, 812, 10.1016/j.jval.2012.06.014

Ramaekers, 2013, Protons in head-and-neck cancer: bridging the gap of evidence, Int J Radiat Oncol Biol Phys, 85, 1282, 10.1016/j.ijrobp.2012.11.006

Schulz, 2016, Expected clinical benefits and challenges of particle therapy for paediatric tumours, Physica Med: Eur J Med Phys, 32, 184, 10.1016/j.ejmp.2016.07.314

Allen Li, 2012, The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM, Med Phys, 39, 1386, 10.1118/1.3685447

Lyman, 1985, Complication probability as assessed from dose-volume histograms, Radiat Res, 104, S13, 10.2307/3576626

Kutcher, 1989, Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method gerald, Int J Radiat Oncol Biol Phys, 16, 1623, 10.1016/0360-3016(89)90972-3

Bentzen, 2010, Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues, Int J Radiat Oncol Biol Phys, 76, S3, 10.1016/j.ijrobp.2009.09.040

Rubin, 2014

Schneider, 2011, Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy, Theor Biol Med Modell, 8, 1, 10.1186/1742-4682-8-27

Santos, 2016, Risk estimation of second primary cancers after breast radiotherapy, Acta Oncol, 1

Life Tables, States, Territories and Australia, 2013–2015; 2016. http://www.abs.gov.au/AUSSTATS/[email protected]/Lookup/3302.0.55.001Main+Features12013-2015?OpenDocument, accessed: 23-06-2017.

Efron, 2016

Bijman, 2017, Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy, Acta Oncol, 1

Lundkvist, 2005, Economic evaluation of proton radiation therapy in the treatment of breast cancer, Radiother Oncol, 75, 179, 10.1016/j.radonc.2005.03.006

Eddy, 2012, Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force–7, Med Decis Making, 32, 733, 10.1177/0272989X12454579

Munzenrider, 1999, Proton therapy for tumors of the skull base, Strahlenther Onkol, 175, 57, 10.1007/BF03038890

Hug, 2002, Proton radiotherapy in management of pediatric base of skull tumors, Int J Radiat Oncol Biol Phys, 52, 1017, 10.1016/S0360-3016(01)02725-0

Noël, 2005, Chordomas of the base of the skull and upper cervical spine. one hundred patients irradiated by a 3D conformal technique combining photon and proton beams, Acta Oncol, 44, 700, 10.1080/02841860500326257

Ares, 2009, Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report, Int J Radiat Oncol Biol Phys, 75, 1111, 10.1016/j.ijrobp.2008.12.055

Rombi, 2013, Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at Paul Scherrer Institute, Int J Radiat Oncol Biol Phys, 86, 578, 10.1016/j.ijrobp.2013.02.026

Yasuda, 2012, Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients, Neurosurg Rev, 35, 171, 10.1007/s10143-011-0334-5

Staab, 2011, Spot-scanning-based proton therapy for extracranial chordoma, Int J Radiat Oncol Biol Phys, 81, e489, 10.1016/j.ijrobp.2011.02.018

Cummings, 1983, Chordoma: the results of megavoltage radiation therapy, Int J Radiat Oncol Biol Phys, 9, 633, 10.1016/0360-3016(83)90228-6

Fuller, 1988, Radiotherapy for chordoma, Int J Radiat Oncol Biol Phys, 15, 331, 10.1016/S0360-3016(98)90012-8

Henderson, 2009, Treatment of chordomas with cyberknife: Georgetown University experience and treatment recommendations, Neurosurgery, 64, A44, 10.1227/01.NEU.0000341166.09107.47

Mayo, 2010, Radiation associated brainstem injury, Int J Radiat Oncol Biol Phys, 76, S36, 10.1016/j.ijrobp.2009.08.078

Kirkpatrick, 2010, Radiation dose–volume effects in the spinal cord, Int J Radiat Oncol Biol Phys, 76, S42, 10.1016/j.ijrobp.2009.04.095

Debus, 1997, Brainstem tolerance to conformal radiotherapy of skull base tumors, Int J Radiat Oncol Biol Phys, 39, 967, 10.1016/S0360-3016(97)00364-7

Abbatucci, 1978, Radiation myelopathy of the cervical spinal cord: time, dose and volume factors, Int J Radiat Oncol Biol Phys, 4, 239, 10.1016/0360-3016(78)90144-X

Deasy, 2010, Radiotherapy dose–volume effects on salivary gland function, Int J Radiat Oncol Biol Phys, 76, S58, 10.1016/j.ijrobp.2009.06.090

Fagundes, 1995, Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse, Int J Radiat Oncol Biol Phys, 33, 579, 10.1016/0360-3016(95)02014-3

Landolfi, 1998, Adult brainstem gliomas, Neurology, 51, 1136, 10.1212/WNL.51.4.1136

Cohen, 1989, Malignant astrocytomas of the spinal cord, J Neurosurg, 70, 50, 10.3171/jns.1989.70.1.0050

Baleriaux, 1999, Spinal cord tumors, Eur Radiol, 9, 1252, 10.1007/s003300050831

Pfreundner, 1999, Carcinoma of the external auditory canal and middle ear, Int J Radiat Oncol Biol Phys, 44, 777, 10.1016/S0360-3016(98)00531-8

Rush, 1982, Optic glioma: long-term follow-up of 85 histopathologically verified cases, Ophthalmology, 89, 1213, 10.1016/S0161-6420(82)34650-3

Storey, 2001, Postoperative radiotherapy for malignant tumors of the submandibular gland, Int J Radiat Oncol Biol Phys, 51, 952, 10.1016/S0360-3016(01)01724-2

Tengs, 2000, One thousand health-related quality-of-life estimates, Med Care, 583, 10.1097/00005650-200006000-00004

Oken, 1982, Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol, 5, 649, 10.1097/00000421-198212000-00014

Thông tin
Thông tin xuất bản

Physica Medica

Tập 44

72-82

Thông tin tác giả